Clinical Trial Update: Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate [Phase 2]

View source ↗

Summary

Phase 2 study evaluating megestrol acetate for management of atypical endometrial hyperplasia and endometrial carcinoma. Results were posted in 2016 after study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Endometrial Hyperplasia
• Endometrial Carcinoma

Drugs mentioned

• Megestrol acetate (megestrol acetate)

Snippet

Sponsor: NYU Langone Health | Conditions: Atypical Endometrial Hyperplasia, Endometrial Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2016-07-01